INVA vs NDAQ · P/E 3.6, rev $217.6M vs P/E 41, rev $2.53B
Innoviva Inc (INVA) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported INVA revenue for 2026-06-30 was $217.6M. Net income was $103.2M. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
INVA currently screens at market cap $1.66B and trailing P/E 3.6. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the INVA and NDAQ stock pages for the full models.
Not investment advice.